- Home
- ELUT vs LMT Comparison
ELUT vs LMT Comparison
Compare ELUT & LMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELUT
- LMT
- Stock Information
- Founded
- ELUT 2015
- LMT 1912
- Country
- ELUT United States
- LMT United States
- Employees
- ELUT N/A
- LMT N/A
- Industry
- ELUT Medical Specialities
- LMT Military/Government/Technical
- Sector
- ELUT Health Care
- LMT Industrials
- Exchange
- ELUT Nasdaq
- LMT Nasdaq
- Market Cap
- ELUT 94.0M
- LMT N/A
- IPO Year
- ELUT 2020
- LMT N/A
- Fundamental
- Price
- ELUT $1.99
- LMT $471.44
- Analyst Decision
- ELUT Strong Buy
- LMT Buy
- Analyst Count
- ELUT 2
- LMT 13
- Target Price
- ELUT $9.00
- LMT $528.69
- AVG Volume (30 Days)
- ELUT 40.2K
- LMT 1.5M
- Earning Date
- ELUT 05-08-2025
- LMT 04-22-2025
- Dividend Yield
- ELUT N/A
- LMT 2.78%
- EPS Growth
- ELUT N/A
- LMT N/A
- EPS
- ELUT N/A
- LMT 23.17
- Revenue
- ELUT $24,375,000.00
- LMT $71,811,000,000.00
- Revenue This Year
- ELUT $39.35
- LMT $5.74
- Revenue Next Year
- ELUT $61.26
- LMT $3.77
- P/E Ratio
- ELUT N/A
- LMT $20.48
- Revenue Growth
- ELUT N/A
- LMT 3.12
- 52 Week Low
- ELUT $1.79
- LMT $418.88
- 52 Week High
- ELUT $5.24
- LMT $618.95
- Technical
- Relative Strength Index (RSI)
- ELUT 39.97
- LMT 54.02
- Support Level
- ELUT $1.79
- LMT $463.46
- Resistance Level
- ELUT $2.07
- LMT $479.00
- Average True Range (ATR)
- ELUT 0.20
- LMT 10.47
- MACD
- ELUT -0.00
- LMT -0.47
- Stochastic Oscillator
- ELUT 33.08
- LMT 60.49
About ELUT Elutia Inc.
Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.